Glenmark Pharmaceuticals

“We are glad to introduce this innovative fixed-dose combination”: Alok Malik

Glenmark Pharmaceuticals has originated a fixed-dose combination of its novel, patent preserved and globally examined Sodium-Glucose Co-Transporter Inhibitor (SGLT2i) –…

Read More »